Drawing for LIVENMA

USPTO serial 97395076

LIVENMA

Reviewed by CopyMark Law Group

Reg. 7263606Status 700Registered
Filing date
Status date
Registration date
Jan 2, 2024
Examiner
HAN, JOANNA Y
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LIVENMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sean D. Detweiler

Sean D. Detweiler MORSE, BARNES-BROWN & PENDLETON, P.C.480 TOTTEN POND ROAD, 4TH FLOORCITYPOINTWALTHAM, MA 02451

Goods and services

ClassDescriptionStatusFirst use
042Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory genetic testing, medical diagnostic testing, and pharmacogenetics; Pharmaceutical research services; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for conducting pharmaceutical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing on-line non-downloadable software for conducting pharmaceutical researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 2, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 2, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 30, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 29, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 29, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 28, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 15, 2023IUAFUSE AMENDMENT FILED—
Nov 15, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 30, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 30, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 30, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 30, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 27, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 27, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 27, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 27, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 22, 2023DOCKASSIGNED TO EXAMINER—
May 9, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 7, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance